Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Farrell Simon currently holds 30,500 shares of Trevi Therapeutics, Inc. (TRVI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Farrell Simon has been a net neutral trader of TRVI stock. They have purchased $0 and sold $0 worth of shares.
Farrell Simon's most recent insider trade was on Jul 22, 2026, when they sold 30,500 shares at $0.00 per share.
Farrell Simon serves as Executive at Trevi Therapeutics, Inc. (TRVI). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Farrell Simon holds the position of Executive at Trevi Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Farrell Simon has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Farrell Simon was on Mar 7, 2023, when they sold $9.6K worth of TRVI shares. This transaction involved 18,750 shares at $0.51 per share.
Farrell Simon currently owns 30,500 shares of Trevi Therapeutics, Inc. (TRVI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Farrell Simon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Farrell Simon has 4 Form 4 filings on record as an insider at Trevi Therapeutics, Inc..
Set alerts for Farrell Simon and 40,000+ other insiders.